Bortezomib For Injection

Bortenat contains Bortezomib that belongs to a class of medicines known as antineoplastic agents. These medicines are also used for treating multiple myeloma and in curing mantle cell lymphoma. Moreover, this medicine reacts straightaway with certain proteins in the body to arrest the growth of cancer cells. This drug is supplied in 3.5 mg single use vial.

Note: Bortenat is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Frequently Asked Questions 

1. What is the purpose of bortezomib injection?

Ans - Multiple myeloma (blood plasma cell cancer) and mantle cell lymphoma are both conditions that are treated with the injection of bortezomib. It is antineoplastic to use bortezomib (cancer medicine). Cancer cells are hampered in their proliferation before being subsequently eliminated by the body.

2. Is bortezomib a cancer treatment?

Ans - By inhibiting some of the enzymes required for cell growth, the drug bortezomib may prevent the growth of cancerous cells. Lenalidomide is an example of a chemotherapy treatment that stops the growth of cancer cells in one of three ways: by killing the cells, by preventing their division, or by preventing their dissemination. 

3. When does bortezomib start to work?

Ans - According to data from SUMMIT and APEX, the median duration to a first response is 1.3 months, indicating that most patients respond to treatment quickly (Richardson et al 2003, 2005a). 

4. Does bortezomib result in baldness?

Ans - Velcade does not directly cause hair loss, but other medications taken alongside Velcade may cause it as a side effect. People who use Velcade along with the cytotoxic medication cyclophosphamide, for instance, may experience hair loss.